InsidersTradesSigma
Track the 에이프로젠 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Industrials sector, 에이프로젠 has recorded 153 public disclosures. Market capitalisation: €56.8bn. The latest transaction was disclosed on 16 July 2026 (Purchase). Among the most active insiders: 지베이스. Every trade is accessible without an account.
147
Insider Decl.
n/a
Thresholds
€1m
22 ops.
Buy Volume
€3m
68 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,551 of 29,057 companies
9.1
score / 100
Value1
Quality18
FCF yld-142%
Earn yld-154%
EV/EBITDA·
ROE-30%
Gross mgn28%
Net mgn-60%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 July 2026
Declarations153 total
Other
Other
Other
Other
Other
Other
25 of 153 declarations
Acerca de 에이프로젠
Aprogen es una empresa que opera en el sector industrial, cotiza en el XKRX. Se centra en el desarrollo y la producción de productos biofarmacéuticos.